Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan‐Long Chuang, Jia‐Horng Kao, Rong‐Nan Chien et al.|Journal of Gastroenterology and Hepatology|2016Cited by 27
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Chung‐Feng Huang, Ming‐Lung Yu, Hsueh‐Chou Lai et al.|The American Journal of Gastroenterology|2020Cited by 27
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)Wei‐Fan Hsu, Cheng‐Yuan Peng, Pei‐Chien Tsai et al.|Journal of Gastroenterology and Hepatology|2021Cited by 23
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis CShih-Jer Hsu, Wan‐Long Chuang, Ming‐Lung Yu et al.|Journal of the Formosan Medical Association|2020Cited by 22
Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in TaiwanYi‐Shin Huang, Chen‐Yi Wu, Ting‐Tsung Chang et al.|Liver International|2021Cited by 21